| T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia A Mardiros, C Dos Santos, T McDonald, CE Brown, X Wang, LE Budde, ... Blood, The Journal of the American Society of Hematology 122 (18), 3138-3148, 2013 | 442 | 2013 |
| Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy M Jonnalagadda, A Mardiros, R Urak, X Wang, LJ Hoffman, A Bernanke, ... Molecular Therapy 23 (4), 757-768, 2015 | 230 | 2015 |
| Review of rodent euthanasia methods NH Shomer, KH Allen-Worthington, DL Hickman, M Jonnalagadda, ... Journal of the American Association for Laboratory Animal Science 59 (3 …, 2020 | 97 | 2020 |
| An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil KL Flannigan, MR Taylor, SK Pereira, J Rodriguez-Arguello, AW Moffat, ... The Journal of Heart and Lung Transplantation 37 (9), 1047-1059, 2018 | 80 | 2018 |
| Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes H Yuan, L Lanting, ZG Xu, SL Li, P Swiderski, S Putta, M Jonnalagadda, ... American Journal of Physiology-Renal Physiology 295 (2), F605-F617, 2008 | 79 | 2008 |
| Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy M Jonnalagadda, CE Brown, WC Chang, JR Ostberg, SJ Forman, ... PloS one 8 (6), e65519, 2013 | 60 | 2013 |
| Comparison of a Supraglottic Airway Device (v-gel®) with Blind Orotracheal Intubation in Rabbits S Engbers, A Larkin, N Rousset, M Prebble, M Jonnalagadda, CG Knight, ... Frontiers in Veterinary Science 4, 49, 2017 | 44 | 2017 |
| Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase M Jonnalagadda, CE Brown, WC Chang, JR Ostberg, SJ Forman, ... Gene therapy 20 (8), 853-860, 2013 | 31 | 2013 |
| T cells expressing CD123-specific cytolytic effector functions and anti-tumor effects against human acute myeloid leukemia A Mardiros, C Dos Santos, T McDonald, CE Brown, X Wang, LE Budde, ... Blood 122, 3138-3148, 2013 | 8 | 2013 |
| Chimeric antigen receptors (CARs) incorporating mutations in the IgG4 Fc spacer region to eliminate Fc receptor recognition results in improved CAR T cell persistence and anti … M Jonnalagadda, A Mardiros, L Hoffman, A Bernanke, WC Chang, ... Journal for immunotherapy of cancer 1, 1-1, 2013 | 4 | 2013 |
| Difficult orotracheal intubation in a rabbit resulting from the presence of faecal pellets in the oropharynx S Engbers, A Larkin, M Jonnalagadda, M Prebble, N Rousset, CG Knight, ... Veterinary Record Case Reports 4 (1), e000265, 2016 | 3 | 2016 |
| Response to Protocol Review Scenario: More or less administrative burden J Tetens-Woodring, G Babcock, M Jonnalagadda Lab Animal 45 (8), 289-289, 2016 | | 2016 |
| Response to Protocol Review Scenario: Do it by policy M Jonnalagadda, RW Ermel Lab Animal 41 (9), 250-250, 2012 | | 2012 |
| Do it by policy RESPONSE M Jonnalagadda, RW Ermel LAB ANIMAL 41 (9), 250-250, 2012 | | 2012 |
| Selection in NOD-scid IL2R gamma (null) Mice of Gene-Modified Human T Cells Expressing Engineered Human Enzymes that Confer Resistance to Lymphotoxic Drugs M Jonnalagadda, CE Brown, WC Chang, J Ostberg, SJ Forman, ... JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE 50 (5 …, 2011 | | 2011 |
| In Vivo Selection of Gene Modified T Cells Using Engineered Human Enzymes Resistant to Clinical Immunosuppressive Drugs M Jonnalagadda, WC Chang, M Jensen MOLECULAR THERAPY 17, S218-S219, 2009 | | 2009 |
| Multiple campuses, one IACUC: how many AVs? Campus AVs plus an institutional veterinarian. M Jonnalagadda, RW Ermel Lab Animal 38 (4), 113-114, 2009 | | 2009 |
| Response to Protocol Review Scenario: Campus AVs plus an institutional veterinarian M Jonnalagadda, RW Ermel Lab Animal 38 (4), 113-114, 2009 | | 2009 |
| Mycophenolate Mofetil Selection of Gene Modified T Cells With an Engineered Human Inosine Monophosphate Dehydrogenase II (IMPDH2) M Jonnalagadda, WC Chang, MC Jensen JOURNAL OF IMMUNOTHERAPY 31 (9), 923-923, 2008 | | 2008 |
